GB0419176D0 - Method of treatment and compositions - Google Patents

Method of treatment and compositions

Info

Publication number
GB0419176D0
GB0419176D0 GB0419176A GB0419176A GB0419176D0 GB 0419176 D0 GB0419176 D0 GB 0419176D0 GB 0419176 A GB0419176 A GB 0419176A GB 0419176 A GB0419176 A GB 0419176A GB 0419176 D0 GB0419176 D0 GB 0419176D0
Authority
GB
United Kingdom
Prior art keywords
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0419176A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cyclacel Ltd
Original Assignee
Cyclacel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyclacel Ltd filed Critical Cyclacel Ltd
Priority to GB0419176A priority Critical patent/GB0419176D0/en
Publication of GB0419176D0 publication Critical patent/GB0419176D0/en
Priority to AU2005276231A priority patent/AU2005276231A1/en
Priority to PL05775408T priority patent/PL1799230T3/en
Priority to ES05775408T priority patent/ES2403558T3/en
Priority to PCT/GB2005/003350 priority patent/WO2006021803A2/en
Priority to CN2005800370898A priority patent/CN101048160B/en
Priority to MX2007002169A priority patent/MX2007002169A/en
Priority to CA002576159A priority patent/CA2576159A1/en
Priority to JP2007528987A priority patent/JP5117189B2/en
Priority to EP05775408A priority patent/EP1799230B1/en
Priority to US11/660,249 priority patent/US20080125404A1/en
Priority to US13/464,362 priority patent/US8809350B2/en
Ceased legal-status Critical Current

Links

GB0419176A 2004-08-27 2004-08-27 Method of treatment and compositions Ceased GB0419176D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GB0419176A GB0419176D0 (en) 2004-08-27 2004-08-27 Method of treatment and compositions
US11/660,249 US20080125404A1 (en) 2004-08-27 2005-08-25 Purine and Pyrimidine Cdk Inhitbitors and Their use for The Treatment of Autoimmune Diseases
PCT/GB2005/003350 WO2006021803A2 (en) 2004-08-27 2005-08-25 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
PL05775408T PL1799230T3 (en) 2004-08-27 2005-08-25 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
ES05775408T ES2403558T3 (en) 2004-08-27 2005-08-25 Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases
AU2005276231A AU2005276231A1 (en) 2004-08-27 2005-08-25 Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases
CN2005800370898A CN101048160B (en) 2004-08-27 2005-08-25 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
MX2007002169A MX2007002169A (en) 2004-08-27 2005-08-25 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases.
CA002576159A CA2576159A1 (en) 2004-08-27 2005-08-25 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
JP2007528987A JP5117189B2 (en) 2004-08-27 2005-08-25 Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases
EP05775408A EP1799230B1 (en) 2004-08-27 2005-08-25 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
US13/464,362 US8809350B2 (en) 2004-08-27 2012-05-04 Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0419176A GB0419176D0 (en) 2004-08-27 2004-08-27 Method of treatment and compositions

Publications (1)

Publication Number Publication Date
GB0419176D0 true GB0419176D0 (en) 2004-09-29

Family

ID=33104750

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0419176A Ceased GB0419176D0 (en) 2004-08-27 2004-08-27 Method of treatment and compositions

Country Status (1)

Country Link
GB (1) GB0419176D0 (en)

Similar Documents

Publication Publication Date Title
LT1791791T (en) Methods and compositions for treatment of water
GB2423928B (en) Methods and compositions for treating pain
EP1786265A4 (en) Novel compositions and methods of treatment
GB2414666B (en) Sanitizing composition and method of preparation
IL178996A0 (en) Thienopyridinone compounds and methods of treatment
EP1737482A4 (en) Compositions and methods for treating diseases
ZA200704677B (en) Compositions and methods for the treatment of autism
EP1765260A4 (en) Sanitizing composition and method of preparation
IL179931A0 (en) Compositions and methods for treatment of cardiovascular disease
IL182436A0 (en) Thienopyridinone compounds and methods of treatment
IL174627A0 (en) Compositions and methods for treatment of burns
HK1121952A1 (en) Methods and compositions for treating conditions
EP1696910A4 (en) Compositions and methods for treatment of fibrosis
EP1720563A4 (en) Methods and compositions for the treatment of inflammation
HK1109576A1 (en) Aequorin-containing compositions and methods of using same
EP1773349A4 (en) Methods and compositions for treatment of preeclampsia
ZA200709024B (en) Method of well treatment and construction
EP1824462A4 (en) Composition and method for the treatment of tauopathies
GB0520930D0 (en) Composition and method of use
EP1784193A4 (en) Composition and method for treatment and prevention of atherosclerosis
GB0324523D0 (en) Compositions and methods of treatment
GB0504657D0 (en) Compositions and methods of treatment
GB0419175D0 (en) Method of treatment and compositions
GB0419176D0 (en) Method of treatment and compositions
AU2004900546A0 (en) Method of Treatment and Composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)